Research Study

Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis.

📅 2025 🔗 DOI: 10.1007/s12020-024-04013-w
Citation
Ma J., Liu Y., Hu J., Liu X., Xia Y. et al. (2025). Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis.. Endocrine. DOI: 10.1007/s12020-024-04013-w
View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.